Current Health Receives FDA Clearance for Hospital Care

We are thrilled to announce we have received Class II clearance from the U.S. Food and Drug Administration (FDA) for hospital care. At Current Health, we are committed to changing the world through proactive healthcare and this achievement is just the first step towards monitoring the health of every human being to identify sickness earlier with the goal of saving lives. Today, we’re in the hospital, tomorrow the home, and in the near future, we’ll be everywhere. We are just getting started!

Why is this important?

Faced with an aging population and strained healthcare systems worldwide, U.S. and U.K. healthcare providers are deploying Current Health to change their patient delivery models from reactive to proactive care to produce better patient outcomes. Our approach will help health organizations reduce unnecessary hospital readmissions for patients whose conditions deteriorate after treatment — an expensive and cumbersome clinical burden that costs U.S. hospitals more than $40 billion annually.

Mount Sinai Brooklyn is working with Current Health to detect patient deterioration earlier and improve healthcare outcomes, resulting in the safest and highest quality care for patients. Dr. Scott Lorin, president of Mount Sinai Brooklyn, said:

“The Mount Sinai Health System works with innovative and leading-edge companies like Current Health to support our commitment to providing world-class patient care. Current’s continuous and proactive monitoring platform has the potential to alert us to patient deterioration faster and give our team data insights they can act on earlier.”

Built using the world’s largest real-time physiological data set, Current Health is the most accurate, all-in-one wireless wearable currently approved for use in the EU and U.S. Our proprietary algorithms continuously analyze data, along with relevant contextual patient information, to offer actionable and proactive insights into the wearer’s health. We also seamlessly integrates with third-party devices to capture additional metrics, building patient-specific digital therapeutics and recommendations.

Current Health is actively in use with U.K. healthcare providers in a post-acute setting, including Dartford and Gravesham NHS Trust, which serves a local population of 500,000 people. The Dartford and Gravesham NHS Trust Hospital at Home team uses Current to remotely monitor patients after discharge. As a result, clinicians and staff reprioritized home visits based on criticality, resulting in a 22 percent reduction in home visits and fewer hospital readmissions and emergency department visits, which freed up skilled nursing time and helped patients feel safe and secure.

For more information: